Cargando…
Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
Motor symptoms are a core feature of Parkinson’s disease (PD) and cause a significant burden on patients’ quality of life. Oral levodopa is still the most effective treatment, however, the motor benefits are countered by inherent pharmacologic limitations of the drug. Additionally, with disease prog...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287529/ https://www.ncbi.nlm.nih.gov/pubmed/35841520 http://dx.doi.org/10.1007/s40265-022-01747-7 |